These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 17264811

  • 1. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
    Bharat A, Narayanan K, Street T, Fields RC, Steward N, Aloush A, Meyers B, Schuessler R, Trulock EP, Patterson GA, Mohanakumar T.
    Transplantation; 2007 Jan 27; 83(2):150-8. PubMed ID: 17264811
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunological link between primary graft dysfunction and chronic lung allograft rejection.
    Bharat A, Kuo E, Steward N, Aloush A, Hachem R, Trulock EP, Patterson GA, Meyers BF, Mohanakumar T.
    Ann Thorac Surg; 2008 Jul 27; 86(1):189-95; discussion 196-7. PubMed ID: 18573422
    [Abstract] [Full Text] [Related]

  • 4. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection.
    Hasegawa S, Ockner DM, Ritter JH, Patterson GA, Trulock EP, Cooper JD, Wick MR.
    Arch Pathol Lab Med; 1995 May 27; 119(5):432-9. PubMed ID: 7748071
    [Abstract] [Full Text] [Related]

  • 5. Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation.
    Fields RC, Bharat A, Steward N, Aloush A, Meyers BF, Trulock EP, Chapman WC, Patterson GA, Mohanakumar T.
    Transplantation; 2006 Dec 27; 82(12):1596-601. PubMed ID: 17198242
    [Abstract] [Full Text] [Related]

  • 6. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
    Verleden SE, Ruttens D, Vos R, Vandermeulen E, Moelants E, Mortier A, Van Raemdonck DE, Proost P, Schols D, Verleden GM, Vanaudenaerde BM.
    Transplantation; 2015 Jan 27; 99(1):86-93. PubMed ID: 25050473
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation.
    Sekine Y, Bowen LK, Heidler KM, Van Rooijen N, Brown JW, Cummings OW, Wilkes DS.
    J Immunol; 1997 Oct 15; 159(8):4084-93. PubMed ID: 9378999
    [Abstract] [Full Text] [Related]

  • 9. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
    Jaramillo A, Fernández FG, Kuo EY, Trulock EP, Patterson GA, Mohanakumar T.
    Pediatr Transplant; 2005 Feb 15; 9(1):84-93. PubMed ID: 15667618
    [Abstract] [Full Text] [Related]

  • 10. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, Savik K, Reinsmoen NL.
    Transplantation; 2002 Sep 27; 74(6):799-804. PubMed ID: 12364858
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R, O'Brien M, Hogan P, Thornton A, Fowler K, Byrne D, Stephens F, Harrocks S.
    J Heart Valve Dis; 2003 May 27; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibodies to human leukocyte antigens in lung transplantation.
    Hachem RR.
    Clin Transpl; 2011 May 27; ():327-32. PubMed ID: 22755426
    [Abstract] [Full Text] [Related]

  • 16. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E, Milhe F, Badier M, Thomas P, Magnan A, Reynaud-Gaubert M.
    J Heart Lung Transplant; 2006 May 27; 25(5):523-32. PubMed ID: 16678030
    [Abstract] [Full Text] [Related]

  • 17. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G, Amirzagar AA, Pourmand G, Mehrsai AR, Taherimahmoudi M, Baradaran N, Nicknam MH, Ebrahimi Rad MR, Saraji A, Asadpoor AA, Moheiydin M, Nikbin B.
    Transplant Proc; 2009 Sep 27; 41(7):2800-4. PubMed ID: 19765439
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.
    Bharat A, Saini D, Steward N, Hachem R, Trulock EP, Patterson GA, Meyers BF, Mohanakumar T.
    Ann Thorac Surg; 2010 Oct 27; 90(4):1094-101. PubMed ID: 20868794
    [Abstract] [Full Text] [Related]

  • 20. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
    Girnita AL, McCurry KR, Iacono AT, Duquesnoy R, Corcoran TE, Awad M, Spichty KJ, Yousem SA, Burckart G, Dauber JH, Griffith BP, Zeevi A.
    J Heart Lung Transplant; 2004 Oct 27; 23(10):1135-41. PubMed ID: 15477106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.